Zika vaccines shows early signs of promise

Vaccines being developed to arm against the Zika virus have shown early signs of promise.

So far, scientists have found three types of vaccine to offer protection against the illness in tests on rhesus monkeys.

The news comes after the World Health Organisation (WHO) declared Zika a public health emergency, after it was found to cause brain deformities in babies.

Currently, 60 countries and territories now have continuing transmission of Zika, with a small number of cases recently being identified in Scotland.

Dr Ed Wright, senior lecturer and virologist at the University of Westminster, said: "All of the vaccines currently under development are many years away from being licensed and available for widespread public use."

Jonathan Ball, professor of molecular virology at the University of Nottingham, said: "We knew that these vaccines worked in mice and now the researchers have shown that they also protect non-human primates from Zika virus infection.

"The next step will be to see if these vaccines are safe and the scientists hope to start early trials in humans to address this."

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho